Stay updated on OPTIM Study: Immunotherapy in Head and Neck Clinical Trial
Sign up to get notified when there's something new on the OPTIM Study: Immunotherapy in Head and Neck Clinical Trial page.

Latest updates to the OPTIM Study: Immunotherapy in Head and Neck Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site maintenance or release update without altering the study record content.SummaryDifference0.1%

- Check22 days agoChange DetectedThe page revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check37 days agoChange DetectedAdded the disease term 'Squamous cell carcinoma of the head and neck' and introduced a Genetic and Rare Diseases Information Center resources section on the study page.SummaryDifference0.2%

- Check51 days agoChange DetectedRevision tag updated to v3.5.0; previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check58 days agoChange DetectedPage revision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check87 days agoChange DetectedThe page now displays Revision: v3.4.2. The previous funding-status notice and the older Revision: v3.4.1 text have been removed.SummaryDifference0.4%

Stay in the know with updates to OPTIM Study: Immunotherapy in Head and Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OPTIM Study: Immunotherapy in Head and Neck Clinical Trial page.